The report, which levels the same allegations at CVS and Cigna, is the latest indictment of America’s broken healthcare ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...

Witty's comments came during the company's first earnings call since the killing of Brian Thompson, the CEO of the company's ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...